Fresenius Kabi AB
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 4
- Period
- 2 July 2026 – 22 September 2026
Its main clients
- Västra Götalandsregionen · 2 contracts
- Region Blekinge · 1 contract
- Region Stockholm - Fastighets- och servicenämnden/Inköpscentralen · 1 contract
Where and what
Supplies · 4
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 2 March 2027 re-tender around October 2026 |
Anestesi- och plasmaläkemedel 2026
Region Blekinge framework agreement |
CSL Behring Aktiebolag Accord Healthcare AB Takeda Pharma AB hameln pharma AB Abcur AB Baxter Medical Aktiebolag Fresenius Kabi AB Viatris AB FrostPharma AB B. Braun Medical Aktiebolag Aguettant Nordic ApS Octapharma Nordic AB Orifarm Generics AB Abboxia AB Unimedic Pharma AB Sandoz A/S Aspen Pharma Ireland Limited Stragen Nordic A/S Oresunda Pharma ApS 20 bids received |
– |
| 31 October 2028 re-tender around May 2028 |
Nutrition
Västra Götalandsregionen framework agreement |
Danone AB Fresenius Kabi AB Lantmännen Functional Foods AB Nestlé Sverige Aktiebolag Navamedic AB Scandinavian Biopharma Distribution AB 2 bids received |
– |
| 31 October 2028 re-tender around May 2028 |
Sondnäring barn
Västra Götalandsregionen framework agreement |
Nestlé Sverige Aktiebolag Danone AB Fresenius Kabi AB 1 bid received |
– |
Contracts won
| Date | Contract | Buyer | Amount |
|---|---|---|---|
| 22/09/2026 | Sondnäring barn | Västra Götalandsregionen | – |
| 21/09/2026 | Nutrition | Västra Götalandsregionen | – |
| 07/09/2026 | Anestesi- och plasmaläkemedel 2026 | Region Blekinge | – |
| 02/07/2026 | Läkemedel på rekvisition 2026 SLL450 del 2 | Region Stockholm - Fastighets- och servicenämnden/Inköpscentralen | – |
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.